rimonabant has been researched along with (3r)-((2,3-dihydro-5-methyl-3-((4-morpholinyl)methyl)pyrrolo-(1,2,3-de)-1,4-benzoxazin-6-yl)(1-naphthalenyl))methanone in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Alkorta, I; Alsasua, A; Dannert, MT; Goya, P; Hernandez-Folgado, L; Jagerovic, N; MartÃn, MI; Navarro, M; Pascual, D; Rodriguez de Fonseca, F; Serrano, A; Suardiaz, M | 1 |
| Charlier, C; De Martino, P; Di Pace, P; Lambert, DM; Muccioli, GG; Pizza, T; Poppitz, W; Poupaert, JH; Scriba, GK; Wouters, J | 1 |
| Dhawas, A; Goswami, A; Gugale, SB; Jain, MR; Joharapurkar, A; Kadam, P; Kar, SS; Mishra, B; Mitra, P; Patel, JZ; Patel, PR; Sadhwani, N; Sairam, KV; Salunke, RP; Shedage, SA; Soni, R; Srivastava, BK; Unadkat, VB | 1 |
3 other study(ies) available for rimonabant and (3r)-((2,3-dihydro-5-methyl-3-((4-morpholinyl)methyl)pyrrolo-(1,2,3-de)-1,4-benzoxazin-6-yl)(1-naphthalenyl))methanone
| Article | Year |
|---|---|
Discovery of 5-(4-chlorophenyl)-1-(2,4-dichlorophenyl)-3-hexyl-1h-1,2,4-triazole, a novel in vivo cannabinoid antagonist containing a 1,2,4-triazole motif.
Topics: Animals; Behavior, Animal; Binding, Competitive; Cannabinoid Receptor Agonists; Cannabinoid Receptor Antagonists; Cerebellum; Guinea Pigs; Ileum; In Vitro Techniques; Male; Mice; Muscle Contraction; Muscle, Smooth; Radioligand Assay; Rats; Triazoles; Vas Deferens | 2004 |
Synthesis and activity of 1,3,5-triphenylimidazolidine-2,4-diones and 1,3,5-triphenyl-2-thioxoimidazolidin-4-ones: characterization of new CB1 cannabinoid receptor inverse agonists/antagonists.
Topics: Amidohydrolases; Animals; Binding Sites; Binding, Competitive; Brain; CHO Cells; Cricetinae; Cricetulus; Crystallography, X-Ray; Humans; Imidazolidines; Imidazolines; In Vitro Techniques; Male; Models, Molecular; Radioligand Assay; Rats; Rats, Wistar; Receptor, Cannabinoid, CB1; Receptor, Cannabinoid, CB2; Stereoisomerism; Structure-Activity Relationship | 2006 |
Bioisosteric replacement of dihydropyrazole of 4S-(-)-3-(4-chlorophenyl)-N-methyl-N'-[(4-chlorophenyl)-sulfonyl]-4-phenyl-4,5-dihydro-1H-pyrazole-1-caboxamidine (SLV-319) a potent CB1 receptor antagonist by imidazole and oxazole.
Topics: Animals; Combinatorial Chemistry Techniques; Cricetinae; Cricetulus; Drug Design; Humans; Imidazoles; Models, Molecular; Molecular Structure; Oxazoles; Pyrazoles; Receptor, Cannabinoid, CB1; Structure-Activity Relationship; Sulfonamides | 2008 |